Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Therapeutic R&D (research and development) under UK Commons spotlight:

This article was originally published in Clinica

Executive Summary

Therapeutic and fertility research are the subjects of two panel hearings being held by the House of Commons Select Committee for Science and Technology (STC) on November 24 2004, as part of its enquiry into human reproductive technologies and the law. The therapeutic research panel in this tenth oral evidence session will comprise: Professor Roger Pedersen, of the Medical Research Council's (MRC) Centre for Stem Cell Biology and Medicine (Cambridge); Professor Alison Murdoch, consultant gynaecologist and head of the Newcastle Fertility Centre; and Dr Robin Lovell-Badge, head of developmental genetics at the MRC's National Institute for Medical Research.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT060205

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel